EUVIMEDEUVIMED entdecken
Crossref

Electrochemical aptasensing of HER2 breast cancer biomarker using a Ni nanofoam/Ag–Au ternary nanocomposite

Farzaneh Hoseynidokht, Mohammad Mazloum-Ardakani, Fatemeh Hakimian, Nafiseh Sahraei

Analytical and Bioanalytical Chemistry · 2026

DOI: 10.1007/s00216-025-06238-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Farzaneh Hoseynidokht und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Yazd University, Yazd, 89195-741, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Gold, Nickel, Nanocomposites. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human epidermal growth factor receptor 2 (HER2) is a key biomarker associated with breast cancer, and its reliable detection using effective diagnostic tools is clinically significant. Here, we developed an electrochemical aptasensor based on an electroactive labeling strategy for the detection of HER2 using differential pulse voltammetry (DPV). A nickel nanofoam/gold nanoparticles (AuNPs)/silver nanoparticles (AgNPs) nanocomposite was employed as a novel electrode modifier synthesized via a simple, low-cost, and reproducible method. In this design, AuNPs enabled stable aptamer immobilization, while AgNPs acted as electroactive labels, enhancing the current response through a synergistic effect that could not be achieved with either nanoparticle alone. The newly developed aptasensor demonstrated high sensitivity and good reproducibility for HER2 detection. The aptasensor showed a wide linear range of 0.001-100 ng mL-1, a very low limit of detection (LOD) of 0.30 pg mL-1, and a limit of quantification (LOQ) of 1.0 pg mL-1, indicating its significant potential for clinical diagnostic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGoldNickelNanocompositesElectrochemical TechniquesErb-b2 Receptor Tyrosine KinasesSilverMetal NanoparticlesBiomarkers, TumorAptamers, NucleotideBiosensing TechniquesHumansFemaleLimit of DetectionReproducibility of Results

Stichwörter der Autor:innen

Breast cancerElectrochemical aptasensingHER2SerumTernary nanocomposite

Substanzen

GoldNickelErb-b2 Receptor Tyrosine KinasesSilverBiomarkers, TumorAptamers, NucleotideERBB2 protein, human

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Yazd University, Yazd, 89195-741, Iran.
  • Department of Chemistry, Faculty of Science, Yazd University, Yazd, 89195-741, Iran. mazloum@yazd.ac.ir.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Zitieren

APA

Hoseynidokht, F., Mazloum-Ardakani, M., Hakimian, F., & Sahraei, N. (2026). Electrochemical aptasensing of HER2 breast cancer biomarker using a Ni nanofoam/Ag–Au ternary nanocomposite. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-025-06238-8

Vancouver

Hoseynidokht F, Mazloum-Ardakani M, Hakimian F, Sahraei N. Electrochemical aptasensing of HER2 breast cancer biomarker using a Ni nanofoam/Ag–Au ternary nanocomposite. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-025-06238-8

BibTeX
@article{Hoseynidokht2026,
  author = {Hoseynidokht, Farzaneh and Mazloum-Ardakani, Mohammad and Hakimian, Fatemeh and Sahraei, Nafiseh},
  title = {Electrochemical aptasensing of HER2 breast cancer biomarker using a Ni nanofoam/Ag–Au ternary nanocomposite},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  doi = {10.1007/s00216-025-06238-8}
}
Kostenlos starten →